Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial

Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tome, Chip Caine, Ben Corn, Andrew Kanner, Howard Rowley, Vijayananda Kundapur, Albert DeNittis, Jeffrey N. Greenspoon, Andre A. Konski, Glenn S. Bauman, Sunjay Shah, Wenyin Shi, Merideth Wendland, Lisa Kachnic, Minesh P. Mehta

Research output: Contribution to journalArticle

387 Citations (Scopus)

Abstract

Purpose: Hippocampal neural stem-cell injury during whole-brain radiotherapy (WBRT) may play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid conformally the hippocampal neural stem-cell compartment during WBRT (HA-WBRT). RTOG 0933 was a single-arm phase II study of HA-WBRT for brain metastases with prespecified comparison with a historical control of patients treated with WBRT without hippocampal avoidance. Patients and Methods: Eligible adult patients with brain metastases received HA-WBRT to 30 Gy in 10 fractions. Standardized cognitive function and quality-of-life (QOL) assessments were performed at baseline and 2, 4, and 6 months. The primary end point was the Hopkins Verbal Learning Test-Revised Delayed Recall (HVLT-R DR) at 4 months. The historical control demonstrated a 30% mean relative decline in HVLT-R DR from baseline to 4 months. To detect a mean relative decline ≤ 15% in HVLT-R DR after HA-WBRT, 51 analyzable patients were required to ensure 80% statistical power with α = 0.05. Results: Of 113 patients accrued from March 2011 through November 2012, 42 patients were analyzable at 4 months. Mean relative decline in HVLT-R DR from baseline to 4 months was 7.0% (95% CI, -4.7% to 18.7%), significantly lower in comparison with the historical control (P < .001). No decline in QOL scores was observed. Two grade 3 toxicities and no grade 4 to 5 toxicities were reported. Median survival was 6.8 months. Conclusion: Conformal avoidance of the hippocampus during WBRT is associated with preservation of memory and QOL as compared with historical series.

Original languageEnglish (US)
Pages (from-to)3810-3816
Number of pages7
JournalJournal of Clinical Oncology
Volume32
Issue number34
DOIs
StatePublished - Dec 1 2014

Fingerprint

Neural Stem Cells
Radiotherapy
Neoplasm Metastasis
Brain
Verbal Learning
Quality of Life
Intensity-Modulated Radiotherapy
Cognition
Hippocampus
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933) : A phase II multi-institutional trial. / Gondi, Vinai; Pugh, Stephanie L.; Tome, Wolfgang A.; Caine, Chip; Corn, Ben; Kanner, Andrew; Rowley, Howard; Kundapur, Vijayananda; DeNittis, Albert; Greenspoon, Jeffrey N.; Konski, Andre A.; Bauman, Glenn S.; Shah, Sunjay; Shi, Wenyin; Wendland, Merideth; Kachnic, Lisa; Mehta, Minesh P.

In: Journal of Clinical Oncology, Vol. 32, No. 34, 01.12.2014, p. 3810-3816.

Research output: Contribution to journalArticle

Gondi, V, Pugh, SL, Tome, WA, Caine, C, Corn, B, Kanner, A, Rowley, H, Kundapur, V, DeNittis, A, Greenspoon, JN, Konski, AA, Bauman, GS, Shah, S, Shi, W, Wendland, M, Kachnic, L & Mehta, MP 2014, 'Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial', Journal of Clinical Oncology, vol. 32, no. 34, pp. 3810-3816. https://doi.org/10.1200/JCO.2014.57.2909
Gondi, Vinai ; Pugh, Stephanie L. ; Tome, Wolfgang A. ; Caine, Chip ; Corn, Ben ; Kanner, Andrew ; Rowley, Howard ; Kundapur, Vijayananda ; DeNittis, Albert ; Greenspoon, Jeffrey N. ; Konski, Andre A. ; Bauman, Glenn S. ; Shah, Sunjay ; Shi, Wenyin ; Wendland, Merideth ; Kachnic, Lisa ; Mehta, Minesh P. / Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933) : A phase II multi-institutional trial. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 34. pp. 3810-3816.
@article{398298ebf061410cab1ec98429a8f229,
title = "Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial",
abstract = "Purpose: Hippocampal neural stem-cell injury during whole-brain radiotherapy (WBRT) may play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid conformally the hippocampal neural stem-cell compartment during WBRT (HA-WBRT). RTOG 0933 was a single-arm phase II study of HA-WBRT for brain metastases with prespecified comparison with a historical control of patients treated with WBRT without hippocampal avoidance. Patients and Methods: Eligible adult patients with brain metastases received HA-WBRT to 30 Gy in 10 fractions. Standardized cognitive function and quality-of-life (QOL) assessments were performed at baseline and 2, 4, and 6 months. The primary end point was the Hopkins Verbal Learning Test-Revised Delayed Recall (HVLT-R DR) at 4 months. The historical control demonstrated a 30{\%} mean relative decline in HVLT-R DR from baseline to 4 months. To detect a mean relative decline ≤ 15{\%} in HVLT-R DR after HA-WBRT, 51 analyzable patients were required to ensure 80{\%} statistical power with α = 0.05. Results: Of 113 patients accrued from March 2011 through November 2012, 42 patients were analyzable at 4 months. Mean relative decline in HVLT-R DR from baseline to 4 months was 7.0{\%} (95{\%} CI, -4.7{\%} to 18.7{\%}), significantly lower in comparison with the historical control (P < .001). No decline in QOL scores was observed. Two grade 3 toxicities and no grade 4 to 5 toxicities were reported. Median survival was 6.8 months. Conclusion: Conformal avoidance of the hippocampus during WBRT is associated with preservation of memory and QOL as compared with historical series.",
author = "Vinai Gondi and Pugh, {Stephanie L.} and Tome, {Wolfgang A.} and Chip Caine and Ben Corn and Andrew Kanner and Howard Rowley and Vijayananda Kundapur and Albert DeNittis and Greenspoon, {Jeffrey N.} and Konski, {Andre A.} and Bauman, {Glenn S.} and Sunjay Shah and Wenyin Shi and Merideth Wendland and Lisa Kachnic and Mehta, {Minesh P.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1200/JCO.2014.57.2909",
language = "English (US)",
volume = "32",
pages = "3810--3816",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "34",

}

TY - JOUR

T1 - Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933)

T2 - A phase II multi-institutional trial

AU - Gondi, Vinai

AU - Pugh, Stephanie L.

AU - Tome, Wolfgang A.

AU - Caine, Chip

AU - Corn, Ben

AU - Kanner, Andrew

AU - Rowley, Howard

AU - Kundapur, Vijayananda

AU - DeNittis, Albert

AU - Greenspoon, Jeffrey N.

AU - Konski, Andre A.

AU - Bauman, Glenn S.

AU - Shah, Sunjay

AU - Shi, Wenyin

AU - Wendland, Merideth

AU - Kachnic, Lisa

AU - Mehta, Minesh P.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Purpose: Hippocampal neural stem-cell injury during whole-brain radiotherapy (WBRT) may play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid conformally the hippocampal neural stem-cell compartment during WBRT (HA-WBRT). RTOG 0933 was a single-arm phase II study of HA-WBRT for brain metastases with prespecified comparison with a historical control of patients treated with WBRT without hippocampal avoidance. Patients and Methods: Eligible adult patients with brain metastases received HA-WBRT to 30 Gy in 10 fractions. Standardized cognitive function and quality-of-life (QOL) assessments were performed at baseline and 2, 4, and 6 months. The primary end point was the Hopkins Verbal Learning Test-Revised Delayed Recall (HVLT-R DR) at 4 months. The historical control demonstrated a 30% mean relative decline in HVLT-R DR from baseline to 4 months. To detect a mean relative decline ≤ 15% in HVLT-R DR after HA-WBRT, 51 analyzable patients were required to ensure 80% statistical power with α = 0.05. Results: Of 113 patients accrued from March 2011 through November 2012, 42 patients were analyzable at 4 months. Mean relative decline in HVLT-R DR from baseline to 4 months was 7.0% (95% CI, -4.7% to 18.7%), significantly lower in comparison with the historical control (P < .001). No decline in QOL scores was observed. Two grade 3 toxicities and no grade 4 to 5 toxicities were reported. Median survival was 6.8 months. Conclusion: Conformal avoidance of the hippocampus during WBRT is associated with preservation of memory and QOL as compared with historical series.

AB - Purpose: Hippocampal neural stem-cell injury during whole-brain radiotherapy (WBRT) may play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid conformally the hippocampal neural stem-cell compartment during WBRT (HA-WBRT). RTOG 0933 was a single-arm phase II study of HA-WBRT for brain metastases with prespecified comparison with a historical control of patients treated with WBRT without hippocampal avoidance. Patients and Methods: Eligible adult patients with brain metastases received HA-WBRT to 30 Gy in 10 fractions. Standardized cognitive function and quality-of-life (QOL) assessments were performed at baseline and 2, 4, and 6 months. The primary end point was the Hopkins Verbal Learning Test-Revised Delayed Recall (HVLT-R DR) at 4 months. The historical control demonstrated a 30% mean relative decline in HVLT-R DR from baseline to 4 months. To detect a mean relative decline ≤ 15% in HVLT-R DR after HA-WBRT, 51 analyzable patients were required to ensure 80% statistical power with α = 0.05. Results: Of 113 patients accrued from March 2011 through November 2012, 42 patients were analyzable at 4 months. Mean relative decline in HVLT-R DR from baseline to 4 months was 7.0% (95% CI, -4.7% to 18.7%), significantly lower in comparison with the historical control (P < .001). No decline in QOL scores was observed. Two grade 3 toxicities and no grade 4 to 5 toxicities were reported. Median survival was 6.8 months. Conclusion: Conformal avoidance of the hippocampus during WBRT is associated with preservation of memory and QOL as compared with historical series.

UR - http://www.scopus.com/inward/record.url?scp=84912138328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912138328&partnerID=8YFLogxK

U2 - 10.1200/JCO.2014.57.2909

DO - 10.1200/JCO.2014.57.2909

M3 - Article

C2 - 25349290

AN - SCOPUS:84912138328

VL - 32

SP - 3810

EP - 3816

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 34

ER -